Park Ha Biological Technology is trading at $0.44, down 9.3% today, as the stock faces continued volatility and speculative selling following its recent AI-powered skincare partnership rally.
- Shares are pulling back after a parabolic June surge tied to the Star Plus AI ecosystem announcement, leaving the stock vulnerable to profit-taking.
- The company has seen significant price swings since its 1-for-50 reverse split in February, exacerbated by current weakness across the broader biotech sector.